Safety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastoma

Background Combining Gliadel wafers and radiochemotherapy with TMZ may carry the risk of increased adverse events (AE). We analyzed the efficacy and safety in patients with glioblastoma who underwent multimodal treatment with implantation of Gliadel wafers. Methods One hundred sixty-five consecutive...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta neurochirurgica 2012-08, Vol.154 (8), p.1371-1378
Hauptverfasser: De Bonis, Pasquale, Anile, Carmelo, Pompucci, Angelo, Fiorentino, Alba, Balducci, Mario, Chiesa, Silvia, Maira, Giulio, Mangiola, Annunziato
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Combining Gliadel wafers and radiochemotherapy with TMZ may carry the risk of increased adverse events (AE). We analyzed the efficacy and safety in patients with glioblastoma who underwent multimodal treatment with implantation of Gliadel wafers. Methods One hundred sixty-five consecutive patients with newly diagnosed (77 patients) or recurrent (88 patients) glioblastoma were studied. Forty-seven patients underwent surgery + Gliadel. The impact of age (≥65 vs.
ISSN:0001-6268
0942-0940
DOI:10.1007/s00701-012-1413-2